MedWatch

Contera raises USD 29 million from South Korean investors, expands in Denmark

After raising around KRW 35.2 billion from its two South Korean owners, Danish firm Contera Pharma is already looking to recruit managerial staff for its research department in Denmark and work toward its goal of being listed in South Korea.

After a fresh capital injection, Contera keeps moving toward its goal of being listed in South Korea. Photo: Bioinnovation Institute / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles